Shankar Gopi
SEC CIK 1965014 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LRMR | Larimar Therapeutics, Inc. | Chief Development Off | 76.4K | $18.6K | — | 4 | 2023-12-07 | 2026-01-26 |
Most active insiders at LRMR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Deerfield Mgmt HIF, L.P. | Dir, 10%, * Dir by Deputization | $25.00M | — |
| 2 | Hamilton Thomas Edward | Dir | $666.9K | — |
| 3 | THOMAS FRANK E | Dir | $25.0K | — |
| 4 | SHERMAN JEFFREY W | Dir | $25.0K | — |
| 5 | Shankar Gopi | Chief Development Off | — | — |
| 6 | Clayton Russell | Chief Medical Off | — | — |
| 7 | BEN-MAIMON CAROLE | Pres, CEO, Dir | — | — |
| 8 | Celano Michael | CFO | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-27 | 2026-01-26 | LRMR | Larimar Therapeutics, Inc. | Shankar Gopi | Chief Development Off | A - Grant | $0.00 | +25.6K | 76.4K | +50% | $0 |
| D | 2025-01-24 | 2025-01-22 | LRMR | Larimar Therapeutics, Inc. | Shankar Gopi | Chief Development Off | A - Grant | $0.00 | +23.3K | 50.8K | +85% | $0 |
| D | 2024-01-19 | 2024-01-17 | LRMR | Larimar Therapeutics, Inc. | Shankar Gopi | Chief Development Off | A - Grant | $0.00 | +22.5K | 27.5K | +450% | $0 |
| 2023-12-08 | 2023-12-07 | LRMR | Larimar Therapeutics, Inc. | Shankar Gopi | Chief Development Off | P - Purchase | $3.73 | +5,000 | 5,000 | New | +$18.6K |
Purchase Sale Sale after option exercise All abbreviations